ACP: Next-generation antibiotics underused for gram-negative infections
Apr 22, 2024
41.5% of difficult-to-treat resistance episodes were treated exclusively with traditional agents.
2011 to 2020 saw increase in annual prescription meds expenditures
Apr 15, 2024
Metabolic agents were the most costly category; antidiabetic agents were the mostly costly therapeutic area.
More seniors may be willing to take deprescribing advice
By
John Hall
Apr 12, 2024
Providers, however, must continue to check their motivation in cutting back on certain prescriptions, pharmacy experts caution.
Focus on briefs: Medication management
Apr 12, 2024
PharMerica selects SinguLab to deliver pharmacogenomics solutions, Drug shortages shrouded in mystery
One in seven drug supply chain issue reports tied to drug shortages
Apr 10, 2024
Supply disruptions increased for drugs with and without reports at the start of the COVID-19 pandemic.
ACC: Semaglutide beneficial in obesity-related heart failure, type 2 diabetes
Apr 09, 2024
Larger reductions were seen in heart failure-related symptoms and physical limitations for patients with HFpEF and type 2 diabetes.
Long-term care pharmacies forced to borrow to buy resident drugs, close as intermediaries tighten grip...
By
Kimberly Marselas
Apr 08, 2024
Long-term care resident access to prescription drugs is being squeezed as several market and regulatory factors have combined to increase the power that pharmacy benefit managers have over the specialized...
Nirmatrelvir-ritonavir does not speed up alleviation of COVID-19 symptoms
Apr 05, 2024
The time to sustained alleviation of COVID-19 symptoms was not significantly shorter with nirmatrelvir-ritonavir versus placebo.
Lixisenatide reduces motor disability progression in Parkinson’s disease
Apr 04, 2024
Lixisenatide results in less progression of motor disability than placebo at 12 months for individuals with early Parkinson’s disease.
Insulin out-of-pocket cost caps do not increase insulin use
Mar 26, 2024
Caps are associated with a reduction in insulin costs, mainly driven by patients enrolled in health savings accounts.